A Simple HPLC Method for Quantitation of Diacerein in Tablet Dosage Form
 
More details
Hide details
1
Department of Pharmaceutical Chemistry, Ultra College of Pharmacy,Madurai – 625 020Tamil Nadu, India
2
Department of Pharmaceutical Chemistry, Annai JKK Sampoorani Ammal College of Pharmacy, B. Komarapalayam - 638 183 Tamilnadu, India
3
Department of Pharmacy, Faculty of Engineering Tecnology, Annamalai University, Annmalainagar Tamilnadu, India
CORRESPONDING AUTHOR
Keddal G. Lalitha
Department of Pharmaceutical Chemistry, Ultra College of Pharmacy,Madurai – 625 020Tamil Nadu, India
Publish date: 2017-10-05
 
Eurasian J Anal Chem 2010;5(1):81–88
KEYWORDS
ABSTRACT
A simple, economic, accurate reverse phase isocratic RP-HPLC method has been developed for the quatitation of diacerein in tablet dosage form. The quantitation was carried out using Zorbax CN column. The mobile phase was ammonium acetate buffer (pH adjusted to 3.5) : Acetonitrile [53:47]. The LOD and LOQ are found to be 3.952µg/ml and 11.97µg/ml respectively. The flow rate was 1ml/min with UV detection at 254nm.The method has been validated and proved to be accurate, precise, linear, rugged, robust, simple and rapid. The calibration curve was linear in the concentration range 25-150µg/ml with coefficient of correlation 0.99942. The percentage recovery of diacerein was found to be 101.60%.The method is useful in the quality for the estimation of diacerein in tablet dosage form.
 
REFERENCES (9)
1.
Mahajan A, Kulbir Singh, Tandon V R, Sudesh Kumar, Hardeep Kumar (2006) Diacerin: a new symptomatic slow acting drug for osteoarthritis. J K Sci 8(3): 173.
 
2.
Dougados M, Nguyen M, Berdah L, Mazieres B, Vignon E, Lequesne M (2001) Evaluation of the Structure Modifying Effect of Diacerein in hip osteoarthritis. Arthritis Rheum 44: 2539.
 
3.
Fidelix T S, Soares B G, Trevisani V F (2006) Diacerein for osteoarthritis. Cochrane Database Syst Rev (1). 10:1002/14651858.CD.005117. Pub.2.2006.
 
4.
Bruyere O, Burlet N, Delmas P D, Rizzoli R, Cooper C, Reginster J Y (2008) Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system. BMC Musculoskelet Disord 9: 165.
 
5.
Giannellini V, Salvatore F, Bartolucci G, Coran S A, Bambagiotti-Alberti M. (2005) A validated HPLC stability-indicating method for the determination of diacerhein in bulk drug substance. J Pharm Biomed Anal 39: 776.
 
6.
Chakrabarty U S, Mandal U, Bhaumik U, Chatterjee B, Ghosh A, Bose A, Pal T K. (2008) Bioequivalence study of two capsule formulations containing diacerein 50 mg in healthy human subjects. Arzneimittelforschung 58: 405.
 
7.
Ashok C, Golak M, Adwait D, Krishna V, Himani A, Umesh P, Amol G, Srinivas S, Sharad M, Deepali J, Atul C (2009) Isolation and structural elucidation of two impurities from a diacerein bulk drug. J Pharm Biomed Anal 49: 525.
 
8.
ICH, Q3B (1996) Validation of analytical procedures Methodology, International Conference on Harmonization. November 6, 1996, U.S-Department of health & human service, Food & Drug Administration.
 
9.
ICH, Q2A (1994) Validation of analytical procedures Methodology, International Conference on Harmonization. October 27, 1994, Geneva.
 
eISSN:1306-3057